These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 5037043)
1. Chemotherapy of brain tumors. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice. Tator CH J Neurosurg; 1972 Jul; 37(1):1-8. PubMed ID: 5037043 [No Abstract] [Full Text] [Related]
2. Retention of tritiated methotrexate in a transplantable mouse glioma. Tator CH Cancer Res; 1976 Sep; 36(9 pt.1):3058-66. PubMed ID: 975073 [TBL] [Abstract][Full Text] [Related]
3. The uptake of tritiated methotrexate by an experimental glioma. Tator CH Cancer Res; 1971 Nov; 31(11):1600-5. PubMed ID: 5121663 [No Abstract] [Full Text] [Related]
4. Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy. Tator CH; Wassenaar W J Neurosurg; 1977 Feb; 46(2):165-74. PubMed ID: 833633 [TBL] [Abstract][Full Text] [Related]
5. Uptake of tritiated methotrexate by mouse brain tumors after intravenous or intrathecal administration. Ushio Y; Hayakawa T; Mogami H J Neurosurg; 1974 Jun; 40(6):706-16. PubMed ID: 4406460 [No Abstract] [Full Text] [Related]
6. Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma. Levin VA; Clancy TP; Ausman JI; Rall DP J Natl Cancer Inst; 1972 Apr; 48(4):875-83. PubMed ID: 4537157 [No Abstract] [Full Text] [Related]
7. The uptake of hydrocortisone in mouse brain and ependymoblastoma. Schwartz ML; Tator CH; Hoffman HJ J Neurosurg; 1972 Feb; 36(2):178-83. PubMed ID: 5008732 [No Abstract] [Full Text] [Related]
8. Methotrexate permeability and steady-state distribution in the murine ependymoblastoma. Levin VA; Clancy TP; Ausman JI Trans Am Neurol Assoc; 1969; 94():294-6. PubMed ID: 5374467 [No Abstract] [Full Text] [Related]
9. The chemotherapy of intracerebral vs subcutaneous murine gliomas. A comparative study of the effect of VM 26. Shapiro WR Arch Neurol; 1974 Mar; 30(3):222-6. PubMed ID: 4812958 [No Abstract] [Full Text] [Related]
14. Intratumoral methotrexate kinetics in a patient with intracranial anaplastic ependymoma. Geis T; Peters O; Friedrich M; Dränert E; Wolff JE Pediatr Blood Cancer; 2004 Jul; 43(1):78-80. PubMed ID: 15170895 [TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats. Cosolo W; Christophidis N Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195 [TBL] [Abstract][Full Text] [Related]
16. [Incorporation of tritiated thymidine into human brain tumor cells]. Arkhangel'skiĭ VV; Kotel'nikov VM; Kondakova LI Vopr Neirokhir; 1971; 35(1):15-21. PubMed ID: 5562496 [No Abstract] [Full Text] [Related]
17. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors. Shapiro WR Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762 [No Abstract] [Full Text] [Related]
18. The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors. Cotterchio M; Seyfried TN Mol Chem Neuropathol; 1993 Oct; 20(2):163-72. PubMed ID: 8297420 [TBL] [Abstract][Full Text] [Related]
19. Brain tumor chemotherapy with intrathecal methotrexate. Wilson CB; Norrell HA Cancer; 1969 May; 23(5):1038-45. PubMed ID: 5305238 [No Abstract] [Full Text] [Related]
20. Glucose analogues as potential agents for brain tumour diagnosis and treatment. Wassenaar W; Tator CH Trans Am Neurol Assoc; 1973; 98():43-8. PubMed ID: 4784973 [No Abstract] [Full Text] [Related] [Next] [New Search]